首页 > 最新文献

中华老年医学杂志最新文献

英文 中文
Research advances in anti-Aβ targeted therapy for Alzheimer's disease: An update 抗Aβ靶向治疗阿尔茨海默病的研究进展
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.030
Jiyi Xu, Zhi Zhou, B. Qin
The theory of amyloid-induced Alzheimer's disease(AD)has been challenged by the scientific community.However, with the deep study of amyloid beta(Aβ)cascade metabolic reaction process and the characteristics and functions of various Aβ polypeptides, people have a profound understanding of the pathogenesis of AD caused by Aβ.Currently, several Aβ antibodies, including the protofibril selective antibody BAN2401, are in clinical trials for treating Alzheimer's disease.After the good results of targeted therapy for Aβ(Ban2401), this theory has attracted our attention again.In this paper, the pathogenesis of Aβ and the progress of targeted therapy were reviewed systematically. Key words: Alzheimer disease; Amyloid; Targeted therapy
淀粉样蛋白诱导的阿尔茨海默病(AD)理论受到了科学界的挑战。然而,随着对淀粉样蛋白β(Aβ)级联代谢反应过程以及各种Aβ多肽的特征和功能的深入研究,人们对Aβ引起的AD的发病机制有了深刻的了解。目前,包括原纤维选择性抗体BAN2401在内的几种Aβ抗体正在进行治疗阿尔茨海默病的临床试验。在Aβ(Ban2401)靶向治疗取得良好效果后,这一理论再次引起了我们的关注。本文对Aβ的发病机制及靶向治疗进展进行了系统综述。关键词:阿尔茨海默病;淀粉样蛋白;靶向治疗
{"title":"Research advances in anti-Aβ targeted therapy for Alzheimer's disease: An update","authors":"Jiyi Xu, Zhi Zhou, B. Qin","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.030","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.030","url":null,"abstract":"The theory of amyloid-induced Alzheimer's disease(AD)has been challenged by the scientific community.However, with the deep study of amyloid beta(Aβ)cascade metabolic reaction process and the characteristics and functions of various Aβ polypeptides, people have a profound understanding of the pathogenesis of AD caused by Aβ.Currently, several Aβ antibodies, including the protofibril selective antibody BAN2401, are in clinical trials for treating Alzheimer's disease.After the good results of targeted therapy for Aβ(Ban2401), this theory has attracted our attention again.In this paper, the pathogenesis of Aβ and the progress of targeted therapy were reviewed systematically. \u0000 \u0000 \u0000Key words: \u0000Alzheimer disease; Amyloid; Targeted therapy","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1441-1444"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43648504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of Atorvastatin in elderly patients with chronic subdural hematoma after surgical treatments 阿托伐他汀在老年慢性硬膜下血肿术后治疗中的临床疗效
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.019
B. Feng, Guan Wang, Yueda Chen, Zenliang Wang, Jianye Wang, Kun Dong, Xueyan Wang, Cheng-gang Wu, Zhi-yuan Zhou, Qiyang Zhang, Wenfeng Dai
观察老年患者在进行外科手术后,应用阿托伐他汀治疗的临床疗效。回顾性分析天津市中医药大学第二附属医院神经外科和天津市环湖医院收治的80例老年慢性硬膜下血肿(CSDH)行颅骨钻孔引流术患者,术后依据是否应用阿托伐他汀分为观察组36例和对照组44例。结果提示老年CSDH患者术后联合口服阿托伐他汀,能有效减少术后引流管留置时间和住院时间,且提高CSDH患者的治愈率。
观察老年患者在进行外科手术后,应用阿托伐他汀治疗的临床疗效。回顾性分析天津市中医药大学第二附属医院神经外科和天津市环湖医院收治的80例老年慢性硬膜下血肿(CSDH)行颅骨钻孔引流术患者,术后依据是否应用阿托伐他汀分为观察组36例和对照组44例。结果提示老年CSDH患者术后联合口服阿托伐他汀,能有效减少术后引流管留置时间和住院时间,且提高CSDH患者的治愈率。
{"title":"Clinical efficacy of Atorvastatin in elderly patients with chronic subdural hematoma after surgical treatments","authors":"B. Feng, Guan Wang, Yueda Chen, Zenliang Wang, Jianye Wang, Kun Dong, Xueyan Wang, Cheng-gang Wu, Zhi-yuan Zhou, Qiyang Zhang, Wenfeng Dai","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.019","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.019","url":null,"abstract":"观察老年患者在进行外科手术后,应用阿托伐他汀治疗的临床疗效。回顾性分析天津市中医药大学第二附属医院神经外科和天津市环湖医院收治的80例老年慢性硬膜下血肿(CSDH)行颅骨钻孔引流术患者,术后依据是否应用阿托伐他汀分为观察组36例和对照组44例。结果提示老年CSDH患者术后联合口服阿托伐他汀,能有效减少术后引流管留置时间和住院时间,且提高CSDH患者的治愈率。","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1401-1403"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43666504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IgG4-related hypophysitis with the initial symptoms of central diabetes insipidus: a case report IgG4相关垂体炎伴中枢性尿崩症一例
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.027
Tingting Yuan, Guo-yun Wang, Xin Zhao
报道一例主因烦渴、多饮、多尿,禁水垂体加压素试验符合中枢性尿崩症特征,鞍区增强核磁提示垂体和垂体柄炎性病变,实验室追查IgG4明显升高,考虑IgG4相关性垂体炎、中枢性尿崩症、自身免疫性胰腺炎。
Report a case of main cause of thirst, polydipsia, and polyuria. The pituitary vasopressin test after water deprivation is consistent with the characteristics of central diabetes insipidus. Enhanced magnetic resonance imaging in the sellar region indicates inflammatory lesions in the pituitary gland and pituitary stalk. Laboratory investigation shows a significant increase in IgG4, considering IgG4 related pituitary inflammation, central diabetes insipidus, and autoimmune pancreatitis.
{"title":"IgG4-related hypophysitis with the initial symptoms of central diabetes insipidus: a case report","authors":"Tingting Yuan, Guo-yun Wang, Xin Zhao","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.027","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.027","url":null,"abstract":"报道一例主因烦渴、多饮、多尿,禁水垂体加压素试验符合中枢性尿崩症特征,鞍区增强核磁提示垂体和垂体柄炎性病变,实验室追查IgG4明显升高,考虑IgG4相关性垂体炎、中枢性尿崩症、自身免疫性胰腺炎。","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1431-1432"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41692812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy and safety of intravenous thrombolysis in elderly patients with mild ischemic stroke 静脉溶栓治疗老年轻度缺血性脑卒中的疗效和安全性
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.006
Lidong Ding, Zhang-hua Xiao, Huawu Mao, Xiaofang Hang, Xiaobo Lu, Yuqing Shen, Q. Fang, Juemiao Chen
Objective To evaluate the efficacy and safety of intravenous thrombolysis with recombinant tissue-plasminogen activator (rt-PA) in elderly patients with early-stage mild ischemic stroke (IS). Methods This was a prospective, open-label, controlled study.Ninety-four elderly patients with mild IS admitted to our hospital from January 2014 to December 2017 were randomized into a thrombolysis arm (TA, n=46) and a control arm (CA, n=48). The short-term endpoints were the National Institutes of Health stroke scale (NIHSS) scores on 3rd, 7th, 14thday after admission and the secondary endpoints were the modified Rankin Scale (mRS) score and the morbidity of recurrence IS within 90 days.Safety was evaluated by the incidence of intracranial hemorrhage (IH) and early neurological deterioration (END) during hospitalization. Results The baseline NIHSS scores of patients in the TA and CA groups were similar [(4.1±0.7) vs.(4.1±0.7)]. However, there were significant differences in the NIHSS score on 3rd [(3.4±1.2) vs.(4.2±1.4)], 7th[(3.0±1.8) vs.(4.1±1.6)] and 14thday [(2.5±2.0) vs.(3.4±1.6)], respectively, between the TA group and the CA group.Furthermore, the TA group was associated with a significantly higher proportion of patients with good prognosis (mRS, 0-2), compared with the CA group (71.7% vs.35.4%, P 3 could benefit from thrombolytic therapy.There were 1 case of symptomatic IH and 1 case of progressive stroke in the TA group, and 1 case of IH and 2 cases of progressive stroke in the control group.There were no significant differences in the rate of either END or IH between the two groups (P>0.05). Two patients in the TA group and three patients in the control group had recurrent IS within 90 days and the recurrence rate of IS was also similar within 90 days (P>0.05). Conclusions Intravenous thrombolytic therapy with rt-PA can improve the prognosis of elderly patients with mild stroke without increased risk of END, IH, or recurrence of IS. Key words: Stroke; Brain Ischemia; Thrombolytic therapy
目的评价重组组织纤溶酶原激活剂(rt-PA)静脉溶栓治疗老年早期轻度缺血性脑卒中(IS)的疗效和安全性。方法前瞻性、开放标签、对照研究。2014年1月至2017年12月我院收治的94例老年轻度IS患者随机分为溶栓组(TA, n=46)和对照组(CA, n=48)。短期终点为入院后第3、7、14天美国国立卫生研究院卒中量表(NIHSS)评分,次要终点为改良Rankin量表(mRS)评分和90天内IS复发发生率。通过住院期间颅内出血(IH)和早期神经功能恶化(END)的发生率来评估安全性。结果TA组和CA组患者NIHSS基线评分相近[(4.1±0.7)比(4.1±0.7)]。然而,TA组与CA组在第3天[(3.4±1.2)比(4.2±1.4)]、第7天[(3.0±1.8)比(4.1±1.6)]、第14天[(2.5±2.0)比(3.4±1.6)]的NIHSS评分差异有统计学意义。此外,TA组预后良好的患者比例(mRS, 0-2)明显高于CA组(71.7% vs.35.4%), p3可以从溶栓治疗中获益。TA组出现症状性IH 1例,进展性卒中1例,对照组出现IH 1例,进展性卒中2例。两组间END和IH发生率比较,差异均无统计学意义(P < 0.05)。TA组2例患者与对照组3例患者在90天内出现IS复发,90天内IS复发率相似(P < 0.05)。结论rt-PA静脉溶栓治疗可以改善老年轻度脑卒中患者的预后,且不会增加END、IH和IS复发的风险。关键词:卒中;脑缺血;溶栓治疗
{"title":"The efficacy and safety of intravenous thrombolysis in elderly patients with mild ischemic stroke","authors":"Lidong Ding, Zhang-hua Xiao, Huawu Mao, Xiaofang Hang, Xiaobo Lu, Yuqing Shen, Q. Fang, Juemiao Chen","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.006","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.006","url":null,"abstract":"Objective \u0000To evaluate the efficacy and safety of intravenous thrombolysis with recombinant tissue-plasminogen activator (rt-PA) in elderly patients with early-stage mild ischemic stroke (IS). \u0000 \u0000 \u0000Methods \u0000This was a prospective, open-label, controlled study.Ninety-four elderly patients with mild IS admitted to our hospital from January 2014 to December 2017 were randomized into a thrombolysis arm (TA, n=46) and a control arm (CA, n=48). The short-term endpoints were the National Institutes of Health stroke scale (NIHSS) scores on 3rd, 7th, 14thday after admission and the secondary endpoints were the modified Rankin Scale (mRS) score and the morbidity of recurrence IS within 90 days.Safety was evaluated by the incidence of intracranial hemorrhage (IH) and early neurological deterioration (END) during hospitalization. \u0000 \u0000 \u0000Results \u0000The baseline NIHSS scores of patients in the TA and CA groups were similar [(4.1±0.7) vs.(4.1±0.7)]. However, there were significant differences in the NIHSS score on 3rd [(3.4±1.2) vs.(4.2±1.4)], 7th[(3.0±1.8) vs.(4.1±1.6)] and 14thday [(2.5±2.0) vs.(3.4±1.6)], respectively, between the TA group and the CA group.Furthermore, the TA group was associated with a significantly higher proportion of patients with good prognosis (mRS, 0-2), compared with the CA group (71.7% vs.35.4%, P 3 could benefit from thrombolytic therapy.There were 1 case of symptomatic IH and 1 case of progressive stroke in the TA group, and 1 case of IH and 2 cases of progressive stroke in the control group.There were no significant differences in the rate of either END or IH between the two groups (P>0.05). Two patients in the TA group and three patients in the control group had recurrent IS within 90 days and the recurrence rate of IS was also similar within 90 days (P>0.05). \u0000 \u0000 \u0000Conclusions \u0000Intravenous thrombolytic therapy with rt-PA can improve the prognosis of elderly patients with mild stroke without increased risk of END, IH, or recurrence of IS. \u0000 \u0000 \u0000Key words: \u0000Stroke; Brain Ischemia; Thrombolytic therapy","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1344-1347"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42002756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study of health status in Hainan centenarians 海南省百岁老人健康状况研究
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.022
Yao Yao, S. Fu, Chi Zhang, Faqin Lyu, Fu Zhang, F. Luan, Yali Zhao
Objective To evaluate the health status of Hainan centenarians and compare the gender disparity, and to determine whether the'male-female health-survival paradox’is present among them. Methods A cross-sectional study was conducted on the health status and gender disparity of individuals aged 100 and over in Hainan province from June 2014 to December 2016.Data of sociodemographics, lifestyles as well as health-related parameters were collected.The multi-dimensional health assessment of centenarians was conducted based on the recognition of standard on Chinese healthy elderly in 2013. Results A total of 940 centenarians(men 18.6%, women 81.4%)were included.The prevalences of hypertension, diabetes and dyslipidemia were 66.1%, 9.8%, and 21.2%, respectively, while no significant gender difference was found.Male centenarians were more independent in activity of daily living than did female centenarians(41.1% vs.25.9%, P<0.001). The prevalences of dementia(7.7% vs.4.0%)and depression(33.6% vs.18.9%)were more dominant in females than in males.Multivariate logistic regression showed that the proportions of functional disability, depression and sleep disorders were higher in female centenarians than in male centenarians(P<0.05)after adjusting for general demographic characteristics, lifestyle and other health indicators. Conclusions Although the female proportion dominates the centenarian population, female general health states are worse than male centenarians.More attentions on physical and mental health should be paid to the female centenarians. Key words: Centenarians; Health assessment
目的评价海南百岁老人的健康状况,比较其性别差异,确定百岁老人中是否存在“男性-女性健康-生存悖论”。方法对2014年6月至2016年12月海南省100岁及以上人群健康状况及性别差异进行横断面研究。收集了社会人口统计学、生活方式和健康相关参数的数据。根据2013年《中国健康老年人标准》的认定,对百岁老人进行多维度健康评价。结果共纳入940名百岁老人,其中男性18.6%,女性81.4%。高血压、糖尿病和血脂异常患病率分别为66.1%、9.8%和21.2%,性别差异无统计学意义。男性百岁老人的日常生活活动独立性高于女性百岁老人(41.1%比25.9%,P<0.001)。痴呆(7.7% vs.4.0%)和抑郁症(33.6% vs.18.9%)的患病率女性高于男性。多因素logistic回归分析显示,经一般人口学特征、生活方式等健康指标调整后,女性百岁老人的功能障碍、抑郁和睡眠障碍比例高于男性百岁老人(P<0.05)。结论虽然百岁老人中女性占主导地位,但女性百岁老人总体健康状况差于男性百岁老人。对女性百岁老人的身心健康应给予更多的关注。关键词:百岁老人;健康评估
{"title":"A study of health status in Hainan centenarians","authors":"Yao Yao, S. Fu, Chi Zhang, Faqin Lyu, Fu Zhang, F. Luan, Yali Zhao","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.022","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.022","url":null,"abstract":"Objective \u0000To evaluate the health status of Hainan centenarians and compare the gender disparity, and to determine whether the'male-female health-survival paradox’is present among them. \u0000 \u0000 \u0000Methods \u0000A cross-sectional study was conducted on the health status and gender disparity of individuals aged 100 and over in Hainan province from June 2014 to December 2016.Data of sociodemographics, lifestyles as well as health-related parameters were collected.The multi-dimensional health assessment of centenarians was conducted based on the recognition of standard on Chinese healthy elderly in 2013. \u0000 \u0000 \u0000Results \u0000A total of 940 centenarians(men 18.6%, women 81.4%)were included.The prevalences of hypertension, diabetes and dyslipidemia were 66.1%, 9.8%, and 21.2%, respectively, while no significant gender difference was found.Male centenarians were more independent in activity of daily living than did female centenarians(41.1% vs.25.9%, P<0.001). The prevalences of dementia(7.7% vs.4.0%)and depression(33.6% vs.18.9%)were more dominant in females than in males.Multivariate logistic regression showed that the proportions of functional disability, depression and sleep disorders were higher in female centenarians than in male centenarians(P<0.05)after adjusting for general demographic characteristics, lifestyle and other health indicators. \u0000 \u0000 \u0000Conclusions \u0000Although the female proportion dominates the centenarian population, female general health states are worse than male centenarians.More attentions on physical and mental health should be paid to the female centenarians. \u0000 \u0000 \u0000Key words: \u0000Centenarians; Health assessment","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1413-1417"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42178644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Analysis of drug susceptibility and risk factors for drug resistance of Escherichia coli in elderly patients with urinary tract infection 老年尿路感染患者大肠杆菌耐药性及危险因素分析
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.012
P. Zhen, L. Gu, Ya-Liang Chen, Ming Hu
Objective To investigate the risk factors for drug resistance of urinary tract infections-causing Escherichia coli producing extended spectrum beta-Lactamases (ESBLs) in elderly people (≥65 years old), in order to provide evidence for rational use of antibiotics in clinic. Methods Clinical data of elderly patients diagnosed as urinary tract infections in Beijing Chao-Yang Hospital from January 2016 to December 2017 were retrospectively analyzed. According to whether ESBLs were produced by Escherichia coli isolated from urine samples, the patients were divided into the ESBLs-producing E. Coli group (ESBLs group) and the control group. Single factor analysis was performed by Chi-square test.Logistic regression analysis was used to analyze the risk factors for ESBLs-producing Escherichia coli infections in urinary tract on the basis of statistical significance. Results A total of 452 strains of Escherichia coli were isolated, including 253 strains (55.97%) producing ESBLs, and 199 strains (44.03%) not producing ESBLs. The ureteral calculi (OR=2.675, 95%CI: 1.129-6.341), urinary obstructive diseases (≥ 2 kinds) (OR=8.680, 95%CI: 2.508-30.040), indwelling catheters (OR=5.762, 95%CI: 2.698-12.155), antibiotic treatment more than 2 weeks for urinary tract infections within one year (OR=3.461, 95%CI: 1.766-6.784) were independent risk factors for ESBLs-producing Escherichia coli urinary tract infections. The incidence rate of Escherichia coli resistance to various antibiotics was higher in elderly patients with urinary tract infection than in non-elderly patients. Conclusions Escherichia coli producing ESBLs can be easily isolated from elderly patients with urinary tract obstructive diseases, indwelling catheters and repeated long-term administration of broad-spectrum antibiotics. The proportion of ESBLs Escherichia coli-caused urinary tract infections is higher in elderly patients. Thereby, carbapenems or piperacillin/tazobactam is the reasonable antibiotics. Ampicillin, piperacillin, levofloxacin and ciprofloxacin should not be the first choice for the treatment of urinary tract infections in the elderly. Key words: Urinary tract infections; Escherichia coli infections; Drug tolerance
目的探讨老年人(≥65岁)尿路感染致大肠杆菌超广谱β-内酰胺酶(ESBLs)耐药性的危险因素,为临床合理使用抗生素提供依据。方法回顾性分析2016年1月至2017年12月北京朝阳医院诊断为尿路感染的老年患者的临床资料。根据从尿液中分离出的大肠杆菌是否产生ESBLs,将患者分为产ESBLs的大肠杆菌组(ESBLs组)和对照组。采用卡方检验进行单因素分析。采用Logistic回归分析法对尿路产ESBLs大肠杆菌感染的危险因素进行统计学分析。结果共分离到452株大肠杆菌,其中253株(55.97%)产ESBLs,199株(44.03%)不产ESBLs。输尿管结石(OR=2.675,95%CI:1.129-6.341)、尿路梗阻性疾病(≥2种)(OR=8.680,95%CI:2.508-30.040)、留置导管(OR=5.762,95%CI:2.698-12.155)、1年内尿路感染2周以上抗生素治疗(OR=3.461,95%CI:1.766-6.784)是ESBLs产生大肠杆菌尿路感染的独立危险因素。老年尿路感染患者的大肠杆菌对各种抗生素的耐药性发生率高于非老年患者。结论产ESBLs的大肠杆菌可容易地从患有尿路梗阻性疾病、留置导尿管和长期重复使用广谱抗生素的老年患者中分离出来。ESBLs大肠杆菌引起尿路感染的比例在老年患者中较高。因此,碳青霉烯类或哌拉西林/他唑巴坦是合理的抗生素。氨苄西林、哌拉西林、左氧氟沙星和环丙沙星不应作为治疗老年人尿路感染的首选药物。关键词:尿路感染;大肠杆菌感染;药物耐受性
{"title":"Analysis of drug susceptibility and risk factors for drug resistance of Escherichia coli in elderly patients with urinary tract infection","authors":"P. Zhen, L. Gu, Ya-Liang Chen, Ming Hu","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.012","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.012","url":null,"abstract":"Objective \u0000To investigate the risk factors for drug resistance of urinary tract infections-causing Escherichia coli producing extended spectrum beta-Lactamases (ESBLs) in elderly people (≥65 years old), in order to provide evidence for rational use of antibiotics in clinic. \u0000 \u0000 \u0000Methods \u0000Clinical data of elderly patients diagnosed as urinary tract infections in Beijing Chao-Yang Hospital from January 2016 to December 2017 were retrospectively analyzed. According to whether ESBLs were produced by Escherichia coli isolated from urine samples, the patients were divided into the ESBLs-producing E. Coli group (ESBLs group) and the control group. Single factor analysis was performed by Chi-square test.Logistic regression analysis was used to analyze the risk factors for ESBLs-producing Escherichia coli infections in urinary tract on the basis of statistical significance. \u0000 \u0000 \u0000Results \u0000A total of 452 strains of Escherichia coli were isolated, including 253 strains (55.97%) producing ESBLs, and 199 strains (44.03%) not producing ESBLs. The ureteral calculi (OR=2.675, 95%CI: 1.129-6.341), urinary obstructive diseases (≥ 2 kinds) (OR=8.680, 95%CI: 2.508-30.040), indwelling catheters (OR=5.762, 95%CI: 2.698-12.155), antibiotic treatment more than 2 weeks for urinary tract infections within one year (OR=3.461, 95%CI: 1.766-6.784) were independent risk factors for ESBLs-producing Escherichia coli urinary tract infections. The incidence rate of Escherichia coli resistance to various antibiotics was higher in elderly patients with urinary tract infection than in non-elderly patients. \u0000 \u0000 \u0000Conclusions \u0000Escherichia coli producing ESBLs can be easily isolated from elderly patients with urinary tract obstructive diseases, indwelling catheters and repeated long-term administration of broad-spectrum antibiotics. The proportion of ESBLs Escherichia coli-caused urinary tract infections is higher in elderly patients. Thereby, carbapenems or piperacillin/tazobactam is the reasonable antibiotics. Ampicillin, piperacillin, levofloxacin and ciprofloxacin should not be the first choice for the treatment of urinary tract infections in the elderly. \u0000 \u0000 \u0000Key words: \u0000Urinary tract infections; Escherichia coli infections; Drug tolerance","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1372-1376"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41801313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary discussion for diagnosis of lung diseases: A retrospective analysis of 217 cases undergoing non-tumor lung biopsy 肺部疾病诊断的多学科讨论:217例非肿瘤肺活检的回顾性分析
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.010
F. Fang, Min Zhang, Dijuan Meng, Songtao Hu, Yanming Li, Dong-ge Liu
Objective To study on the diagnostic value of non-tumor lung biopsy by the multidisciplinary discussion including clinician, radiologist and pathologist. Methods Clinical data, imaging data and data of hematoxylin-eosin, immunohistochemical and special staining of pathological lung tissues in 217 cases undergoing non-tumor lung biopsy in Beijing Hospital during July 2015 to July 2018 were retrospectively analyzed.The diagnosis results were summarized and analyzed. Results The age range in 217 cases was 45-89 years, and the median age was 67 years, with 92 females and 125 males.The descriptive diagnoses were found in forty-two cases(19.4%, 42/217). And 175 cases could be confirmatively diagnosed by the multidisciplinary discussion of clinician, radiologist and pathologist.And the diagnostic rate of lung puncture biopsy was 80.6%(175/217 cases). Inflammatory lesions were divided into infection and non-infection.A total of 68 infection cases(31.3%, 68/217)included tuberculosis(43/68, 63.2%), bacterial pneumonia(14/68, 20.6%)and fungal infection(11/68, 16.2%). A total of 107 cases(49.3%, 107/217)of non-infective cases included the following: organized pneumonia(53/107, 49.5%), interstitial pneumonia with autoimmune features(iPAF)(16/107, 15.0%), nonspecific interstitial pneumonia(NSIP)(13/107, 12.1%), hypersensitivity pneumonitis(8/107, 7.5%), granulomatosis with polyangiitis(GPA)(4/107, 3.7%), eosinophilic pneumonia(2/107, 1.9%), sarcoidosis(2/107, 1.9%), acute fibrinous and organizing pneumonia(AFOP)(2/107, 1.9%)and coal pneumoconiosis(2/107, 1.9%, for each), and IgG4 related diseases(1/107, 0.9%), pleuraparenchymal fibroelastomatosis(PPFE)(1/107, 0.9%), asbestos lung(1/107, 0.9%), lipid pneumonia(1/107, 0.9%)and inhaled pneumonia(1/107, 0.9%). Conclusions The diagnoses of the puzzled non-tumor lung diseases were more accurate by pathological examination of lung tissue by using special stain, immunohistochemical stain and other pathological means, and by close multidisciplinary consultation of clinician, radiologist and pathologist, so as to facilitate the diagnosis and treatment of diseases. Key words: Biopsy, needle; Lung disease, interstitial; Immunohistochemistry
目的通过临床医生、放射科医生和病理学家的多学科讨论,探讨非肿瘤肺活检的诊断价值。方法回顾性分析2015年7月至2018年7月在北京医院接受非肿瘤肺活检的217例患者的临床资料、影像学资料及苏木精-伊红、免疫组织化学和病理肺组织特异性染色数据。对诊断结果进行总结和分析。结果217例患者的年龄范围为45-89岁,中位年龄为67岁,其中女性92例,男性125例。描述性诊断42例(19.4%,42/217)。通过临床医生、放射科医生和病理学家的多学科讨论,175例可得到确诊。肺穿刺活检诊断率为80.6%(175/217例)。炎症性病变分为感染性病变和非感染性病变。共有68例感染病例(31.3%,68/217),包括肺结核(43/68,63.2%)、细菌性肺炎(14/68,20.6%)和真菌感染(11/68,16.2%)。共有107例非感染病例(49.3%,107/217)包括:组织性肺炎(53/107,49.5%)、具有自身免疫特征的间质性肺炎(iPAF)(16/107,15.0%)、非特异性间质肺炎(NSIP)(13/107,12.1%),过敏性肺炎(8/107,7.5%)、肉芽肿病伴多血管炎(GPA)(4/107,3.7%)、嗜酸性肺炎(2/107,1.9%)、结节病(2/107、1.9%)、急性纤维蛋白和组织性肺炎(AFOP)(2/107和1.9%)和煤尘沉着病(2/1107和1.9%),以及IgG4相关疾病(1/1007,0.9%)、胸膜膜纤维弹性瘤病(PPFE)(1/1007、0.9%)、石棉肺(1/1007和0.9%),结论应用特殊染色、免疫组织化学染色等病理手段对肺组织进行病理检查,并结合临床医生、放射科医生和病理学家的多学科会诊,对疑难非肿瘤性肺部疾病的诊断更加准确,以便于疾病的诊断和治疗。关键词:活检,针;肺部疾病,间质性;免疫组织化学
{"title":"Multidisciplinary discussion for diagnosis of lung diseases: A retrospective analysis of 217 cases undergoing non-tumor lung biopsy","authors":"F. Fang, Min Zhang, Dijuan Meng, Songtao Hu, Yanming Li, Dong-ge Liu","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.010","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.010","url":null,"abstract":"Objective \u0000To study on the diagnostic value of non-tumor lung biopsy by the multidisciplinary discussion including clinician, radiologist and pathologist. \u0000 \u0000 \u0000Methods \u0000Clinical data, imaging data and data of hematoxylin-eosin, immunohistochemical and special staining of pathological lung tissues in 217 cases undergoing non-tumor lung biopsy in Beijing Hospital during July 2015 to July 2018 were retrospectively analyzed.The diagnosis results were summarized and analyzed. \u0000 \u0000 \u0000Results \u0000The age range in 217 cases was 45-89 years, and the median age was 67 years, with 92 females and 125 males.The descriptive diagnoses were found in forty-two cases(19.4%, 42/217). And 175 cases could be confirmatively diagnosed by the multidisciplinary discussion of clinician, radiologist and pathologist.And the diagnostic rate of lung puncture biopsy was 80.6%(175/217 cases). Inflammatory lesions were divided into infection and non-infection.A total of 68 infection cases(31.3%, 68/217)included tuberculosis(43/68, 63.2%), bacterial pneumonia(14/68, 20.6%)and fungal infection(11/68, 16.2%). A total of 107 cases(49.3%, 107/217)of non-infective cases included the following: organized pneumonia(53/107, 49.5%), interstitial pneumonia with autoimmune features(iPAF)(16/107, 15.0%), nonspecific interstitial pneumonia(NSIP)(13/107, 12.1%), hypersensitivity pneumonitis(8/107, 7.5%), granulomatosis with polyangiitis(GPA)(4/107, 3.7%), eosinophilic pneumonia(2/107, 1.9%), sarcoidosis(2/107, 1.9%), acute fibrinous and organizing pneumonia(AFOP)(2/107, 1.9%)and coal pneumoconiosis(2/107, 1.9%, for each), and IgG4 related diseases(1/107, 0.9%), pleuraparenchymal fibroelastomatosis(PPFE)(1/107, 0.9%), asbestos lung(1/107, 0.9%), lipid pneumonia(1/107, 0.9%)and inhaled pneumonia(1/107, 0.9%). \u0000 \u0000 \u0000Conclusions \u0000The diagnoses of the puzzled non-tumor lung diseases were more accurate by pathological examination of lung tissue by using special stain, immunohistochemical stain and other pathological means, and by close multidisciplinary consultation of clinician, radiologist and pathologist, so as to facilitate the diagnosis and treatment of diseases. \u0000 \u0000 \u0000Key words: \u0000Biopsy, needle; Lung disease, interstitial; Immunohistochemistry","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1363-1367"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43675785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report of sarcomatoid carcinoma of the renal pelvis in elderly patient 老年肾盂肉瘤样癌1例报告
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.028
K. Lei, Ming Ma, Xu Wang, T. Sun
肾盂肉瘤样癌是一种极为罕见的恶性肿瘤,目前国内外报道较少,本患者男,63岁,因双侧腰部疼痛不适2年,加重1月于2010年5月入院。入院诊断:双肾结石并双肾积水,尿路感染。经抗感染治疗后在全麻下行经皮肾镜左肾结石Ⅰ期钬激光碎石术。术中见左侧肾盂内大量乳头状新生物及灰白色坏死物质,行术中冰冻活检,提示尿路上皮癌,遂终止手术。首次手术1周后,于全麻下行后腹腔镜左侧肾盂癌根治术。术中因肾脏与周围组织粘连紧密,不易分离,遂改行开放手术,切除左肾及左输尿管,并在左输尿管入膀胱处行袖套状切除。术后病理诊断:左肾盂肉瘤样癌。建议患者术后转肿瘤科进一步治疗,但患者拒绝,出院后定期电话随访,随访至术后第10个月时患者死亡,死亡原因为肿瘤晚期恶病质。患者临床表现不典型,预后差。迄今为止我院仅收治1例。
Sarcoma like carcinoma of the renal pelvis is an extremely rare malignant tumor, and there are few reports at home and abroad. This patient, a 63 year old man, was admitted to the hospital in May 2010 due to bilateral lumbar pain and discomfort for 2 years, which worsened in January. Admission diagnosis: bilateral kidney stones with hydronephrosis, urinary tract infection. After undergoing anti infection treatment, percutaneous nephrolithotripsy for left renal calculi under general anesthesia was performed using phase I holmium laser lithotripsy. During the operation, a large amount of papillary new organisms and gray white necrotic substances were found in the left renal pelvis. A frozen biopsy was performed during the operation, indicating urothelial carcinoma, and the surgery was terminated. One week after the first surgery, laparoscopic radical resection of left renal pelvis cancer was performed under general anesthesia. Due to the tight adhesion between the kidney and surrounding tissues during the surgery, it was difficult to separate. Therefore, an open surgery was performed to remove the left kidney and ureter, and a sleeve shaped resection was performed at the entrance of the left ureter into the bladder. Postoperative pathological diagnosis: Sarcoma like carcinoma of the left renal pelvis. It is recommended that the patient be transferred to the oncology department for further treatment after surgery, but the patient refused. After discharge, the patient will be followed up regularly by phone, and the patient will die by the 10th month after surgery. The cause of death is late stage cachexia of the tumor. The patient's clinical manifestations are atypical and the prognosis is poor. So far, only one case has been admitted to our hospital.
{"title":"A case report of sarcomatoid carcinoma of the renal pelvis in elderly patient","authors":"K. Lei, Ming Ma, Xu Wang, T. Sun","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.028","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.028","url":null,"abstract":"肾盂肉瘤样癌是一种极为罕见的恶性肿瘤,目前国内外报道较少,本患者男,63岁,因双侧腰部疼痛不适2年,加重1月于2010年5月入院。入院诊断:双肾结石并双肾积水,尿路感染。经抗感染治疗后在全麻下行经皮肾镜左肾结石Ⅰ期钬激光碎石术。术中见左侧肾盂内大量乳头状新生物及灰白色坏死物质,行术中冰冻活检,提示尿路上皮癌,遂终止手术。首次手术1周后,于全麻下行后腹腔镜左侧肾盂癌根治术。术中因肾脏与周围组织粘连紧密,不易分离,遂改行开放手术,切除左肾及左输尿管,并在左输尿管入膀胱处行袖套状切除。术后病理诊断:左肾盂肉瘤样癌。建议患者术后转肿瘤科进一步治疗,但患者拒绝,出院后定期电话随访,随访至术后第10个月时患者死亡,死亡原因为肿瘤晚期恶病质。患者临床表现不典型,预后差。迄今为止我院仅收治1例。","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1433-1434"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41604945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of micronutrients supplement on geriatric cognitive function: The latest research progresses 微量营养素补充剂对老年人认知功能的影响:最新研究进展
Pub Date : 2019-12-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.12.029
Q. Ren
Geriatric ability to live independently will be severely impaired when mild cognitive impairments(MCI)eventually develop into dementia.Patients with dementia usually suffer from micronutrients deficiencies(MNDs). In turn, MNDs may accelerate cognitive decline based on disruption of one carbon metabolism, DNA damage repair, mitochondrial function and glucose, lipid and phospholipids metabolism which lead to the damage of neurotransmitter synthesis, myelination and synaptogenesis.Clinical evidences show that the oral supplementation of B-group vitamins(vitamin B6 10-25 mg/d, vitamin B120.025-0.500 mg/d and folate 0.4-2.0 mg/d)and specific micronutrients compounds for at least 3 months may improve overall cognitive function and short-term memory ability of the elderly.More double-blind, placebo-controlled, randomized human intervention studies are still needed to evaluate effects of micronutrients supplementation on geriatric cognitive function and to determine the requirements, dosage and time of intervention. Key words: Micronutrient; Cognitive function
当轻度认知障碍(MCI)最终发展为痴呆时,老年人独立生活的能力将严重受损。痴呆症患者通常患有微量营养素缺乏症。反过来,MND可能会基于单碳代谢、DNA损伤修复、线粒体功能以及葡萄糖、脂质和磷脂代谢的破坏而加速认知能力下降,从而导致神经递质合成、髓鞘形成和突触发生的损伤。临床证据表明,口服补充B族维生素(维生素B6 10-25 mg/d、维生素B120.025-0.500 mg/d和叶酸0.4-2.0 mg/d)和特定微量营养素化合物至少3个月,可以改善老年人的整体认知功能和短期记忆能力。仍然需要更多的双盲、安慰剂对照、随机的人类干预研究来评估补充微量营养素对老年人认知功能的影响,并确定干预的要求、剂量和时间。关键词:微量营养素;认知功能
{"title":"The effect of micronutrients supplement on geriatric cognitive function: The latest research progresses","authors":"Q. Ren","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.12.029","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.12.029","url":null,"abstract":"Geriatric ability to live independently will be severely impaired when mild cognitive impairments(MCI)eventually develop into dementia.Patients with dementia usually suffer from micronutrients deficiencies(MNDs). In turn, MNDs may accelerate cognitive decline based on disruption of one carbon metabolism, DNA damage repair, mitochondrial function and glucose, lipid and phospholipids metabolism which lead to the damage of neurotransmitter synthesis, myelination and synaptogenesis.Clinical evidences show that the oral supplementation of B-group vitamins(vitamin B6 10-25 mg/d, vitamin B120.025-0.500 mg/d and folate 0.4-2.0 mg/d)and specific micronutrients compounds for at least 3 months may improve overall cognitive function and short-term memory ability of the elderly.More double-blind, placebo-controlled, randomized human intervention studies are still needed to evaluate effects of micronutrients supplementation on geriatric cognitive function and to determine the requirements, dosage and time of intervention. \u0000 \u0000 \u0000Key words: \u0000Micronutrient; Cognitive function","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1435-1440"},"PeriodicalIF":0.0,"publicationDate":"2019-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43593975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interpretation of the Asia-Pacific clinical practice guidelines for the management of frailty 亚太地区虚弱管理临床实践指南解读
Pub Date : 2019-11-14 DOI: 10.3760/CMA.J.ISSN.0254-9026.2019.11.005
J. Chu, Xujiao Chen
{"title":"The interpretation of the Asia-Pacific clinical practice guidelines for the management of frailty","authors":"J. Chu, Xujiao Chen","doi":"10.3760/CMA.J.ISSN.0254-9026.2019.11.005","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.0254-9026.2019.11.005","url":null,"abstract":"","PeriodicalId":9997,"journal":{"name":"中华老年医学杂志","volume":"38 1","pages":"1213-1215"},"PeriodicalIF":0.0,"publicationDate":"2019-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48407502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华老年医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1